In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile

被引:51
作者
Karlowsky, James A. [1 ]
Laing, Nancy M. [1 ]
Zhanel, George G. [1 ]
机构
[1] Univ Manitoba, Fac Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
关键词
D O I
10.1128/AAC.00476-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Agar dilution antimicrobial susceptibility testing (CLSI, M11-A7, 2007) performed for 208 toxin-producing clinical isolates of Clostridium difficile resulted in OPT-80 MICs ranging from 0.06 to 1 mu g/ml, with 90% of the isolates inhibited by a concentration of 0.5 mu g/ml. The in vitro activity of OPT-80 was independent of the susceptibilities of isolates to nine other antimicrobial agents.
引用
收藏
页码:4163 / 4165
页数:3
相关论文
共 25 条
[1]   In vitro activity of OPT-80 against clostridium difcile [J].
Ackermann, G ;
Löffler, B ;
Adler, D ;
Rodloff, AC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2280-2282
[2]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[3]   Clinical recognition and diagnosis of Clostridium difficile infection [J].
Bartlett, John G. ;
Gerding, Dale N. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 :S12-S18
[4]   In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in southern Quebec, Canada [J].
Bourgault, Anne-Marie ;
Lamothe, Francois ;
Loo, Vivian G. ;
Poirier, Louise .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) :3473-3475
[5]  
Clinical and Laboratory Standards Institute, 2007, M11A7 CLIN LAB STAND
[6]   Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species [J].
Credito, KL ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4430-4434
[7]  
Fekety R, 1997, AM J GASTROENTEROL, V92, P739
[8]   In vitro activities of OPT-80 and comparator drugs against intestinal bacteria [J].
Finegold, SA ;
Molitoris, D ;
Vaisanen, ML ;
Song, YL ;
Liu, CX ;
Bolaños, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4898-4902
[9]   Mutation in the Bacillus subtilis RNA polymerase β′ subunit confers resistance to lipiarmycin [J].
Gualtieri, M ;
Villain-Guillot, P ;
Latouche, J ;
Leonetti, JP ;
Bastide, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :401-402
[10]   In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004 [J].
Hecht, David W. ;
Galang, Minerva A. ;
Sambol, Susan P. ;
Osmolski, James R. ;
Johnson, Stuart ;
Gerding, Dale N. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) :2716-2719